| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Phenols | 15 | 2018 | 42 | 4.480 |
Why?
|
| Benzhydryl Compounds | 15 | 2018 | 27 | 2.940 |
Why?
|
| Occupational Exposure | 9 | 2018 | 60 | 2.700 |
Why?
|
| Prenatal Exposure Delayed Effects | 10 | 2020 | 206 | 2.530 |
Why?
|
| Pregnancy Complications, Infectious | 10 | 2020 | 158 | 2.500 |
Why?
|
| Pregnancy | 51 | 2022 | 1555 | 2.240 |
Why?
|
| Abortion, Spontaneous | 8 | 2014 | 49 | 1.870 |
Why?
|
| Adult | 55 | 2020 | 7255 | 1.670 |
Why?
|
| Humans | 79 | 2022 | 16832 | 1.640 |
Why?
|
| Maternal Exposure | 5 | 2020 | 84 | 1.630 |
Why?
|
| Endocrine Disruptors | 5 | 2018 | 9 | 1.380 |
Why?
|
| Female | 61 | 2022 | 12193 | 1.360 |
Why?
|
| Pediatric Obesity | 3 | 2019 | 101 | 1.350 |
Why?
|
| Critical Illness | 3 | 2020 | 53 | 1.330 |
Why?
|
| Influenza, Human | 8 | 2022 | 292 | 1.290 |
Why?
|
| Premature Birth | 5 | 2020 | 133 | 1.210 |
Why?
|
| Pregnancy Complications | 10 | 2015 | 202 | 1.150 |
Why?
|
| Dietary Supplements | 3 | 2016 | 83 | 1.100 |
Why?
|
| Pregnancy Outcome | 9 | 2014 | 160 | 1.090 |
Why?
|
| China | 13 | 2018 | 129 | 1.060 |
Why?
|
| Sudden Infant Death | 5 | 2008 | 8 | 1.010 |
Why?
|
| Anti-Bacterial Agents | 3 | 2019 | 145 | 1.000 |
Why?
|
| Male | 33 | 2020 | 9556 | 0.990 |
Why?
|
| Air Pollutants, Occupational | 3 | 2011 | 14 | 0.980 |
Why?
|
| Infant, Newborn | 19 | 2020 | 828 | 0.980 |
Why?
|
| Risk Factors | 24 | 2016 | 3108 | 0.940 |
Why?
|
| Young Adult | 22 | 2020 | 2456 | 0.920 |
Why?
|
| Sepsis | 4 | 2016 | 64 | 0.900 |
Why?
|
| Alcohol Drinking | 3 | 2014 | 298 | 0.880 |
Why?
|
| Health Maintenance Organizations | 3 | 2017 | 358 | 0.870 |
Why?
|
| Spermatozoa | 3 | 2015 | 4 | 0.830 |
Why?
|
| Fetal Growth Retardation | 2 | 2016 | 11 | 0.820 |
Why?
|
| Cohort Studies | 21 | 2020 | 2396 | 0.820 |
Why?
|
| Adolescent | 22 | 2017 | 3464 | 0.810 |
Why?
|
| Environmental Exposure | 4 | 2015 | 120 | 0.760 |
Why?
|
| Pregnancy Trimester, First | 5 | 2015 | 45 | 0.750 |
Why?
|
| Hospital Mortality | 2 | 2014 | 134 | 0.750 |
Why?
|
| Prospective Studies | 13 | 2021 | 1186 | 0.750 |
Why?
|
| Pre-Eclampsia | 4 | 2015 | 41 | 0.740 |
Why?
|
| California | 17 | 2021 | 2244 | 0.720 |
Why?
|
| Influenza Vaccines | 4 | 2020 | 300 | 0.710 |
Why?
|
| Caffeine | 2 | 2014 | 17 | 0.700 |
Why?
|
| Sleep | 3 | 2008 | 54 | 0.690 |
Why?
|
| Algorithms | 3 | 2020 | 210 | 0.680 |
Why?
|
| Depression | 3 | 2022 | 479 | 0.660 |
Why?
|
| Forecasting | 1 | 2020 | 67 | 0.640 |
Why?
|
| Artificial Intelligence | 1 | 2020 | 26 | 0.640 |
Why?
|
| Magnetic Fields | 3 | 2020 | 6 | 0.630 |
Why?
|
| Critical Care | 1 | 2020 | 62 | 0.630 |
Why?
|
| Obesity | 5 | 2022 | 811 | 0.620 |
Why?
|
| Radiation Exposure | 1 | 2020 | 5 | 0.620 |
Why?
|
| Risk | 5 | 2014 | 453 | 0.620 |
Why?
|
| Blood Culture | 1 | 2020 | 6 | 0.610 |
Why?
|
| DNA Methylation | 2 | 2018 | 44 | 0.610 |
Why?
|
| Case-Control Studies | 14 | 2016 | 995 | 0.600 |
Why?
|
| Electromagnetic Fields | 3 | 2011 | 4 | 0.600 |
Why?
|
| Child Development | 1 | 2020 | 58 | 0.590 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2020 | 64 | 0.580 |
Why?
|
| Abnormalities, Drug-Induced | 3 | 2015 | 15 | 0.570 |
Why?
|
| Middle Aged | 17 | 2015 | 7515 | 0.530 |
Why?
|
| Folic Acid | 2 | 2022 | 29 | 0.530 |
Why?
|
| Antiviral Agents | 3 | 2014 | 92 | 0.500 |
Why?
|
| Elective Surgical Procedures | 1 | 2017 | 10 | 0.500 |
Why?
|
| State Health Plans | 1 | 2017 | 30 | 0.500 |
Why?
|
| Postoperative Care | 1 | 2017 | 16 | 0.500 |
Why?
|
| Overweight | 2 | 2022 | 262 | 0.490 |
Why?
|
| Erectile Dysfunction | 3 | 2013 | 18 | 0.490 |
Why?
|
| Health Plan Implementation | 1 | 2017 | 34 | 0.490 |
Why?
|
| Medical Informatics | 1 | 2016 | 34 | 0.490 |
Why?
|
| RNA, Long Noncoding | 1 | 2016 | 5 | 0.480 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 1 | 2016 | 10 | 0.480 |
Why?
|
| Epigenesis, Genetic | 1 | 2016 | 25 | 0.480 |
Why?
|
| Delivery of Health Care, Integrated | 3 | 2017 | 515 | 0.480 |
Why?
|
| Inpatients | 2 | 2016 | 78 | 0.470 |
Why?
|
| Semen | 2 | 2018 | 3 | 0.470 |
Why?
|
| Evidence-Based Medicine | 2 | 2016 | 160 | 0.460 |
Why?
|
| Infant, Small for Gestational Age | 2 | 2016 | 55 | 0.460 |
Why?
|
| Hormones | 1 | 2015 | 11 | 0.460 |
Why?
|
| Nose | 1 | 2015 | 2 | 0.450 |
Why?
|
| Turbinates | 1 | 2015 | 2 | 0.450 |
Why?
|
| Specimen Handling | 1 | 2015 | 23 | 0.440 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 2015 | 8 | 0.440 |
Why?
|
| Antidepressive Agents, Second-Generation | 1 | 2015 | 17 | 0.440 |
Why?
|
| Herpes Genitalis | 1 | 2014 | 3 | 0.430 |
Why?
|
| Child | 7 | 2020 | 2433 | 0.430 |
Why?
|
| Central Nervous System Stimulants | 1 | 2014 | 23 | 0.430 |
Why?
|
| Paternal Exposure | 2 | 2011 | 3 | 0.430 |
Why?
|
| Retrospective Studies | 13 | 2022 | 2463 | 0.420 |
Why?
|
| Vitamins | 3 | 2022 | 56 | 0.420 |
Why?
|
| Beer | 1 | 2014 | 9 | 0.420 |
Why?
|
| Wine | 1 | 2014 | 17 | 0.410 |
Why?
|
| Pregnant Women | 1 | 2014 | 41 | 0.410 |
Why?
|
| Odds Ratio | 9 | 2015 | 569 | 0.410 |
Why?
|
| Environmental Pollutants | 1 | 2015 | 68 | 0.410 |
Why?
|
| Deoxyribonuclease I | 1 | 2013 | 2 | 0.410 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2014 | 22 | 0.400 |
Why?
|
| Patient Identification Systems | 1 | 2013 | 4 | 0.400 |
Why?
|
| Radiography, Thoracic | 1 | 2013 | 18 | 0.390 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2013 | 19 | 0.390 |
Why?
|
| Infant | 8 | 2020 | 1212 | 0.390 |
Why?
|
| Pneumonia | 1 | 2013 | 47 | 0.380 |
Why?
|
| Risk Adjustment | 1 | 2013 | 17 | 0.380 |
Why?
|
| Iatrogenic Disease | 1 | 2012 | 8 | 0.370 |
Why?
|
| Child, Preschool | 5 | 2020 | 1430 | 0.370 |
Why?
|
| Longitudinal Studies | 3 | 2020 | 653 | 0.370 |
Why?
|
| Severity of Illness Index | 3 | 2014 | 410 | 0.370 |
Why?
|
| Patient Safety | 1 | 2012 | 37 | 0.360 |
Why?
|
| Life Tables | 1 | 2012 | 7 | 0.360 |
Why?
|
| Obstetric Labor, Premature | 2 | 2004 | 8 | 0.360 |
Why?
|
| Fetal Alcohol Spectrum Disorders | 1 | 2011 | 4 | 0.350 |
Why?
|
| Asthma | 2 | 2013 | 375 | 0.350 |
Why?
|
| Genitalia, Male | 1 | 2011 | 1 | 0.350 |
Why?
|
| Prenatal Injuries | 1 | 2011 | 1 | 0.350 |
Why?
|
| Anal Canal | 1 | 2011 | 9 | 0.350 |
Why?
|
| United States | 13 | 2022 | 3858 | 0.340 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2011 | 80 | 0.330 |
Why?
|
| Prevalence | 6 | 2015 | 785 | 0.320 |
Why?
|
| Ejaculation | 1 | 2010 | 1 | 0.320 |
Why?
|
| Libido | 1 | 2010 | 1 | 0.320 |
Why?
|
| Sexual Dysfunctions, Psychological | 1 | 2009 | 1 | 0.310 |
Why?
|
| Magnetics | 1 | 2009 | 1 | 0.310 |
Why?
|
| Paternity | 2 | 2000 | 2 | 0.300 |
Why?
|
| Maternal-Fetal Exchange | 2 | 2011 | 12 | 0.300 |
Why?
|
| Semen Analysis | 3 | 2015 | 3 | 0.300 |
Why?
|
| Proportional Hazards Models | 4 | 2020 | 657 | 0.290 |
Why?
|
| Ventilation | 1 | 2008 | 2 | 0.280 |
Why?
|
| Prenatal Diagnosis | 1 | 2008 | 20 | 0.280 |
Why?
|
| Electronic Health Records | 2 | 2014 | 702 | 0.280 |
Why?
|
| Beverages | 1 | 2008 | 18 | 0.270 |
Why?
|
| Posture | 2 | 2008 | 4 | 0.260 |
Why?
|
| Time Factors | 4 | 2014 | 989 | 0.260 |
Why?
|
| HLA Antigens | 2 | 2004 | 4 | 0.250 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2014 | 353 | 0.240 |
Why?
|
| Pacifiers | 1 | 2005 | 1 | 0.230 |
Why?
|
| Risk Assessment | 6 | 2015 | 1047 | 0.230 |
Why?
|
| Aged | 7 | 2013 | 5901 | 0.230 |
Why?
|
| Eclampsia | 3 | 2014 | 13 | 0.220 |
Why?
|
| Fructose | 2 | 2015 | 6 | 0.220 |
Why?
|
| Inhibins | 2 | 2015 | 2 | 0.210 |
Why?
|
| Sex Hormone-Binding Globulin | 2 | 2015 | 20 | 0.210 |
Why?
|
| Hydrotherapy | 1 | 2003 | 1 | 0.200 |
Why?
|
| Penis | 2 | 2013 | 3 | 0.200 |
Why?
|
| Hot Temperature | 1 | 2003 | 7 | 0.200 |
Why?
|
| Acetaminophen | 1 | 2003 | 4 | 0.200 |
Why?
|
| Aged, 80 and over | 3 | 2013 | 1887 | 0.200 |
Why?
|
| Environmental Monitoring | 2 | 2015 | 26 | 0.190 |
Why?
|
| Databases, Factual | 3 | 2014 | 294 | 0.190 |
Why?
|
| Aspirin | 1 | 2003 | 61 | 0.190 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2003 | 57 | 0.190 |
Why?
|
| Sex Factors | 2 | 2016 | 560 | 0.190 |
Why?
|
| Drug Utilization | 2 | 2013 | 112 | 0.180 |
Why?
|
| Body Mass Index | 3 | 2022 | 925 | 0.180 |
Why?
|
| Osmolar Concentration | 2 | 2013 | 8 | 0.180 |
Why?
|
| Intensive Care Units | 2 | 2013 | 102 | 0.180 |
Why?
|
| Gestational Age | 3 | 2012 | 118 | 0.180 |
Why?
|
| Inflammatory Bowel Diseases | 3 | 2014 | 23 | 0.180 |
Why?
|
| Vaccines, Inactivated | 2 | 2020 | 73 | 0.180 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 2 | 2012 | 56 | 0.170 |
Why?
|
| Population Surveillance | 4 | 2014 | 242 | 0.170 |
Why?
|
| Sensitivity and Specificity | 2 | 2015 | 291 | 0.170 |
Why?
|
| Multicenter Studies as Topic | 2 | 2014 | 76 | 0.170 |
Why?
|
| Automobile Driving | 1 | 2020 | 9 | 0.160 |
Why?
|
| Socioeconomic Factors | 4 | 2013 | 571 | 0.160 |
Why?
|
| Cross-Sectional Studies | 2 | 2015 | 1233 | 0.160 |
Why?
|
| Maternal Age | 2 | 2014 | 73 | 0.160 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2010 | 8 | 0.150 |
Why?
|
| Follow-Up Studies | 5 | 2016 | 1058 | 0.150 |
Why?
|
| Parity | 1 | 2000 | 53 | 0.150 |
Why?
|
| Birth Certificates | 3 | 2013 | 24 | 0.150 |
Why?
|
| Placental Insufficiency | 1 | 1999 | 1 | 0.150 |
Why?
|
| Placenta Previa | 1 | 1999 | 2 | 0.150 |
Why?
|
| Histocompatibility | 1 | 1999 | 1 | 0.150 |
Why?
|
| Placenta | 1 | 1999 | 20 | 0.150 |
Why?
|
| Mothers | 2 | 2014 | 104 | 0.150 |
Why?
|
| Urinary Tract | 1 | 1999 | 2 | 0.140 |
Why?
|
| Infant, Low Birth Weight | 3 | 2011 | 30 | 0.140 |
Why?
|
| Estradiol | 2 | 2015 | 20 | 0.140 |
Why?
|
| Delivery of Health Care | 1 | 2021 | 374 | 0.140 |
Why?
|
| Prenatal Care | 2 | 2016 | 123 | 0.130 |
Why?
|
| Temperature | 1 | 2017 | 18 | 0.130 |
Why?
|
| Survival Rate | 2 | 2012 | 247 | 0.120 |
Why?
|
| Proteins | 1 | 2016 | 13 | 0.120 |
Why?
|
| Fetal Blood | 1 | 2016 | 13 | 0.120 |
Why?
|
| Hospitals | 1 | 2016 | 69 | 0.120 |
Why?
|
| Fetal Development | 1 | 2016 | 15 | 0.120 |
Why?
|
| Congenital Abnormalities | 2 | 2014 | 26 | 0.120 |
Why?
|
| Trimethoprim | 1 | 2015 | 4 | 0.120 |
Why?
|
| Sulfonamides | 1 | 2015 | 13 | 0.120 |
Why?
|
| Preconception Care | 1 | 2016 | 43 | 0.120 |
Why?
|
| Air Pollution, Indoor | 1 | 2015 | 7 | 0.120 |
Why?
|
| Postoperative Complications | 1 | 2017 | 103 | 0.120 |
Why?
|
| Ribonuclease P | 1 | 2015 | 2 | 0.110 |
Why?
|
| Patient Education as Topic | 1 | 2017 | 186 | 0.110 |
Why?
|
| Influenza B virus | 1 | 2015 | 13 | 0.110 |
Why?
|
| Influenza A virus | 1 | 2015 | 13 | 0.110 |
Why?
|
| Prolactin | 1 | 2015 | 4 | 0.110 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2015 | 3 | 0.110 |
Why?
|
| Polymerase Chain Reaction | 1 | 2015 | 48 | 0.110 |
Why?
|
| Androgens | 1 | 2015 | 12 | 0.110 |
Why?
|
| Drug Prescriptions | 2 | 2013 | 137 | 0.110 |
Why?
|
| Quality Improvement | 1 | 2016 | 184 | 0.110 |
Why?
|
| Appetite Regulation | 1 | 2014 | 5 | 0.110 |
Why?
|
| Hypertension, Pregnancy-Induced | 2 | 2014 | 40 | 0.110 |
Why?
|
| Asian Continental Ancestry Group | 1 | 2015 | 69 | 0.110 |
Why?
|
| Patient-Centered Care | 1 | 2017 | 185 | 0.110 |
Why?
|
| Prone Position | 2 | 2005 | 2 | 0.110 |
Why?
|
| Confidence Intervals | 2 | 2008 | 207 | 0.110 |
Why?
|
| Embryonic Development | 1 | 2014 | 1 | 0.110 |
Why?
|
| Sperm Count | 2 | 2015 | 2 | 0.110 |
Why?
|
| Sperm Motility | 2 | 2015 | 2 | 0.110 |
Why?
|
| Pilot Projects | 1 | 2015 | 210 | 0.110 |
Why?
|
| Cleft Lip | 1 | 2014 | 4 | 0.100 |
Why?
|
| Cleft Palate | 1 | 2014 | 5 | 0.100 |
Why?
|
| Ethanol | 1 | 2014 | 19 | 0.100 |
Why?
|
| Immune System Diseases | 1 | 2014 | 2 | 0.100 |
Why?
|
| Fetal Death | 1 | 2014 | 7 | 0.100 |
Why?
|
| Immunosuppressive Agents | 1 | 2014 | 14 | 0.100 |
Why?
|
| Estrogens, Non-Steroidal | 1 | 2013 | 3 | 0.100 |
Why?
|
| Methylation | 1 | 2013 | 1 | 0.100 |
Why?
|
| Gene Expression | 1 | 2013 | 15 | 0.100 |
Why?
|
| Respiratory Tract Infections | 1 | 2014 | 58 | 0.100 |
Why?
|
| Penile Erection | 1 | 2013 | 1 | 0.100 |
Why?
|
| Process Assessment (Health Care) | 1 | 2013 | 22 | 0.100 |
Why?
|
| Residence Characteristics | 1 | 2015 | 244 | 0.100 |
Why?
|
| Anthropometry | 1 | 2013 | 54 | 0.100 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2013 | 85 | 0.100 |
Why?
|
| Perinatal Care | 1 | 2013 | 12 | 0.100 |
Why?
|
| Medical Record Linkage | 1 | 2013 | 35 | 0.100 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2013 | 110 | 0.100 |
Why?
|
| Automation | 1 | 2013 | 22 | 0.100 |
Why?
|
| Surveys and Questionnaires | 2 | 2009 | 1204 | 0.090 |
Why?
|
| Prescriptions | 1 | 2013 | 28 | 0.090 |
Why?
|
| Anticonvulsants | 1 | 2012 | 9 | 0.090 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2013 | 68 | 0.090 |
Why?
|
| Epilepsy | 1 | 2012 | 14 | 0.090 |
Why?
|
| Schizophrenia | 1 | 2013 | 75 | 0.090 |
Why?
|
| Natural Language Processing | 1 | 2013 | 60 | 0.090 |
Why?
|
| Respiratory Insufficiency | 1 | 2012 | 16 | 0.090 |
Why?
|
| Antipsychotic Agents | 1 | 2013 | 50 | 0.090 |
Why?
|
| Databases, Bibliographic | 1 | 2012 | 6 | 0.090 |
Why?
|
| Physicians | 1 | 2013 | 114 | 0.090 |
Why?
|
| Databases as Topic | 1 | 2011 | 19 | 0.090 |
Why?
|
| Biomedical Research | 1 | 2012 | 73 | 0.090 |
Why?
|
| Length of Stay | 1 | 2012 | 169 | 0.090 |
Why?
|
| Heart Defects, Congenital | 1 | 2011 | 17 | 0.090 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2011 | 4 | 0.090 |
Why?
|
| Diabetes, Gestational | 2 | 2014 | 330 | 0.090 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2011 | 110 | 0.080 |
Why?
|
| Epidemiological Monitoring | 1 | 2011 | 21 | 0.080 |
Why?
|
| Logistic Models | 1 | 2013 | 796 | 0.080 |
Why?
|
| Multivariate Analysis | 1 | 2012 | 489 | 0.080 |
Why?
|
| Infertility, Male | 1 | 2010 | 2 | 0.080 |
Why?
|
| Urinalysis | 1 | 2010 | 9 | 0.080 |
Why?
|
| Insurance, Health | 1 | 2012 | 167 | 0.080 |
Why?
|
| Antihypertensive Agents | 1 | 2011 | 157 | 0.080 |
Why?
|
| Tissue Donors | 1 | 2009 | 7 | 0.080 |
Why?
|
| Seasons | 2 | 2022 | 114 | 0.080 |
Why?
|
| Occupational Diseases | 1 | 2009 | 33 | 0.080 |
Why?
|
| Quality Control | 1 | 2009 | 37 | 0.070 |
Why?
|
| Reproductive History | 1 | 2008 | 13 | 0.070 |
Why?
|
| Air Movements | 1 | 2008 | 1 | 0.070 |
Why?
|
| Environmental Pollution | 1 | 2008 | 4 | 0.070 |
Why?
|
| Reference Values | 1 | 2008 | 78 | 0.070 |
Why?
|
| Abortion, Induced | 1 | 2008 | 16 | 0.070 |
Why?
|
| Vaccination | 1 | 2014 | 725 | 0.070 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2008 | 352 | 0.060 |
Why?
|
| Ethnic Groups | 2 | 2013 | 418 | 0.060 |
Why?
|
| Incidence | 1 | 2008 | 1229 | 0.050 |
Why?
|
| Alleles | 1 | 2004 | 59 | 0.050 |
Why?
|
| Muscle, Smooth | 2 | 2013 | 3 | 0.050 |
Why?
|
| Rats, Inbred F344 | 2 | 2013 | 5 | 0.050 |
Why?
|
| Rats | 2 | 2013 | 33 | 0.050 |
Why?
|
| Epidemiologic Studies | 1 | 2003 | 25 | 0.050 |
Why?
|
| San Francisco | 1 | 2003 | 54 | 0.050 |
Why?
|
| Confounding Factors (Epidemiology) | 1 | 2003 | 77 | 0.050 |
Why?
|
| Bias | 1 | 2003 | 90 | 0.050 |
Why?
|
| Survival Analysis | 1 | 2003 | 191 | 0.050 |
Why?
|
| Animals | 2 | 2013 | 237 | 0.050 |
Why?
|
| Mass Screening | 1 | 2008 | 670 | 0.050 |
Why?
|
| Interviews as Topic | 1 | 2003 | 305 | 0.040 |
Why?
|
| Infant, Premature, Diseases | 1 | 2000 | 16 | 0.040 |
Why?
|
| Pandemics | 1 | 2022 | 289 | 0.040 |
Why?
|
| Health Promotion | 1 | 2003 | 277 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2013 | 1098 | 0.040 |
Why?
|
| Death Certificates | 1 | 1999 | 16 | 0.040 |
Why?
|
| Histocompatibility Testing | 1 | 1999 | 1 | 0.040 |
Why?
|
| Fertility | 1 | 1999 | 8 | 0.040 |
Why?
|
| Disease Susceptibility | 1 | 1999 | 36 | 0.040 |
Why?
|
| Anesthesia, Spinal | 1 | 1998 | 1 | 0.040 |
Why?
|
| Spinal Cord | 1 | 1998 | 2 | 0.040 |
Why?
|
| Anesthetics, Local | 1 | 1998 | 6 | 0.040 |
Why?
|
| 5-Methylcytosine | 1 | 2018 | 1 | 0.040 |
Why?
|
| Uterine Hemorrhage | 1 | 1998 | 9 | 0.030 |
Why?
|
| Estrogen Replacement Therapy | 1 | 1998 | 91 | 0.030 |
Why?
|
| Smoking | 1 | 1999 | 373 | 0.030 |
Why?
|
| Adhesives | 1 | 2015 | 1 | 0.030 |
Why?
|
| Construction Materials | 1 | 2015 | 1 | 0.030 |
Why?
|
| Paint | 1 | 2015 | 1 | 0.030 |
Why?
|
| Chills | 1 | 2014 | 3 | 0.030 |
Why?
|
| Myalgia | 1 | 2014 | 10 | 0.030 |
Why?
|
| Cough | 1 | 2014 | 20 | 0.030 |
Why?
|
| Chorioamnionitis | 1 | 2014 | 18 | 0.030 |
Why?
|
| Fever | 1 | 2014 | 52 | 0.030 |
Why?
|
| Hydroxychloroquine | 1 | 2014 | 2 | 0.030 |
Why?
|
| Arthritis | 1 | 2014 | 5 | 0.030 |
Why?
|
| Methotrexate | 1 | 2014 | 3 | 0.030 |
Why?
|
| Self Report | 1 | 2015 | 248 | 0.030 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2014 | 7 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2014 | 24 | 0.030 |
Why?
|
| Electric Stimulation | 1 | 2013 | 3 | 0.030 |
Why?
|
| Nanog Homeobox Protein | 1 | 2013 | 1 | 0.030 |
Why?
|
| Stem Cells | 1 | 2013 | 1 | 0.030 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2013 | 1 | 0.030 |
Why?
|
| Testosterone | 1 | 2013 | 19 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2013 | 15 | 0.030 |
Why?
|
| MicroRNAs | 1 | 2013 | 17 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2013 | 41 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2013 | 81 | 0.020 |
Why?
|
| Oregon | 1 | 2013 | 168 | 0.020 |
Why?
|
| Drug Utilization Review | 1 | 2013 | 21 | 0.020 |
Why?
|
| Data Mining | 1 | 2013 | 18 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2013 | 129 | 0.020 |
Why?
|
| Adverse Drug Reaction Reporting Systems | 1 | 2013 | 97 | 0.020 |
Why?
|
| International Classification of Diseases | 1 | 2013 | 84 | 0.020 |
Why?
|
| Health Services Research | 1 | 2013 | 180 | 0.020 |
Why?
|
| Health Care Surveys | 1 | 2013 | 201 | 0.020 |
Why?
|
| Medical Records | 1 | 2012 | 85 | 0.020 |
Why?
|
| Program Evaluation | 1 | 2012 | 211 | 0.020 |
Why?
|
| Continental Population Groups | 1 | 2013 | 255 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2012 | 325 | 0.020 |
Why?
|
| Centers for Disease Control and Prevention (U.S.) | 1 | 2011 | 32 | 0.020 |
Why?
|
| European Continental Ancestry Group | 1 | 2012 | 400 | 0.020 |
Why?
|
| Research Design | 1 | 2011 | 319 | 0.020 |
Why?
|
| Abortion, Therapeutic | 1 | 2007 | 2 | 0.020 |
Why?
|
| Live Birth | 1 | 2007 | 7 | 0.020 |
Why?
|
| Cesarean Section | 1 | 2007 | 34 | 0.020 |
Why?
|
| Hospitalization | 1 | 2012 | 816 | 0.020 |
Why?
|
| Age Factors | 1 | 2007 | 814 | 0.010 |
Why?
|
| Ampicillin | 1 | 2000 | 2 | 0.010 |
Why?
|
| Bacteriological Techniques | 1 | 2000 | 2 | 0.010 |
Why?
|
| Cephalosporins | 1 | 2000 | 6 | 0.010 |
Why?
|
| Streptococcus agalactiae | 1 | 2000 | 9 | 0.010 |
Why?
|
| Streptococcal Infections | 1 | 2000 | 23 | 0.010 |
Why?
|
| Bupivacaine | 1 | 1998 | 1 | 0.010 |
Why?
|
| Tetracaine | 1 | 1998 | 1 | 0.010 |
Why?
|
| Lidocaine | 1 | 1998 | 5 | 0.010 |
Why?
|
| Patient Readmission | 1 | 2000 | 161 | 0.010 |
Why?
|
| Hyperplasia | 1 | 1998 | 5 | 0.010 |
Why?
|
| Endometrium | 1 | 1998 | 3 | 0.010 |
Why?
|
| Biopsy | 1 | 1998 | 74 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 1998 | 94 | 0.010 |
Why?
|